k7- poliferasi
TRANSCRIPT
-
8/13/2019 K7- Poliferasi
1/59
Prol i ferat ion
Differentiat ion
Control of Normal Cell Proliferation
and Differentiation
Histology Department
Medical Faculty - University of Sumatera Utara
-
8/13/2019 K7- Poliferasi
2/59
Introduction
Cell proliferation
and differentiationare controlled atmultiple levels
Cell fate control is
key to tissueformation duringdevelopment, andits deregulation
results indevelopmentaldefects or intumorigenesis
-
8/13/2019 K7- Poliferasi
3/59
The four essential processes by which
a multicellular organism is made :
Cell proliferation
Cell specialization
Cell interaction
Cell movement
-
8/13/2019 K7- Poliferasi
4/59
-
8/13/2019 K7- Poliferasi
5/59
As a cell differentiates, it becomes smaller, loses its
ability to proliferate, and focuses its energy instead
on performing its function
Prol i ferat ionis the
production of many
cells from a single cell
through repeatedmitosis of daughter
cells.
In general, the more
immature a cell is, thebigger it is and the
greater its ability to
proliferate.
Differentiat ionis the
process of cell
maturation.
Through differentiation,cells acquire their
ultimate functions and
the protein
characteristics requiredto perform those
functions
-
8/13/2019 K7- Poliferasi
6/59
-
8/13/2019 K7- Poliferasi
7/59
-
8/13/2019 K7- Poliferasi
8/59
-
8/13/2019 K7- Poliferasi
9/59
Cell Proliferation
-
8/13/2019 K7- Poliferasi
10/59
regulation of cell
proliferation is maintainedunder strict physiologic
control. Cell proliferation is
typically initiated by theaction of growth factors.
-
8/13/2019 K7- Poliferasi
11/59
TISSUE-PROLIFERATIVE
ACTIVITY The cell cycle consists of :
G1(presynthetic),
S(DNA synthesis),
G2(premitotic),
M(mitotic) phases. The tissues of the body are divided into three groups on
the basis of their proliferative activity
cont inuous ly
d iv id ingt issues=
labi letissues,
cells proliferate
throughout life
Quiescent= stable, tissues
normally have a low level ofreplication; however, cells
from these tissues can
undergo rapid division in
response to stimuli and are
thus capable of reconstitutingthe tissue of origin
Nondiv id ing
=permanentt issues,contain
cells that have left
the cell cycle and
cannot undergo
mitotic division inpostnatal life
-
8/13/2019 K7- Poliferasi
12/59
-
8/13/2019 K7- Poliferasi
13/59
Con t inuously div id ing t issues
(labi letissues) Cells proliferate throughout life, replacing those that are
destroyed.
These tissues include : surface epithelia, such as stratified squamous surfaces of the skin, oral
cavity, vagina, and cervix; the lining mucosa of all the excretory ducts of the glandsof the body
(e.g., salivary glands, pancreas, biliary tract);
the columnar epitheliumof the gastrointestinal tract and uterus;
the transitional epitheliumof the urinary tract,
cells of the bone marrow and hematopoietic tissues. In most of these tissues, mature cells are derived from stem
cells,which have an unlimited capacity to proliferate and whoseprogeny may undergo various streams of differentiation
Q i ( bl i )
-
8/13/2019 K7- Poliferasi
14/59
Quiescent(stable tissues) Normally have a low level of replication; however, cells from
these tissues can undergo rapid division in response to stimuli
and are thus capable of reconstituting the tissue of origin. They are considered to be in the G0 stage of the cell cycle butcan be stimulated to enter G1.
In this category are the parenchymal cells of liver, kidneys, and pancreas;
mesenchymal cells, such as fibroblasts and smooth muscle; vascularendothelial cells;
and resting lymphocytes and other leukocytes.
The regenerative capacity of stable cells is best exemplified bythe ability of the liver to regenerate after partial hepatectomyand after acute chemical injury.
Fibroblasts, endothelial cells, smooth muscle cells,chondrocytes, and osteocytes are quiescent in adult mammalsbut proliferate in response to injury.
Fibroblasts in particular proliferate widely, constituting theconnective tissue res onse to inflammation
-
8/13/2019 K7- Poliferasi
15/59
Nond iv id ing (permanent t issues) Contain cells that have left the cell cycle and cannot
undergo mitotic division in postnatal life.
To this group belong neurons,skeletal and cardiac musclecells.
If neuronsin the central nervous system are destroyed, thetissue is generally replaced by the proliferation of the centralnervous system supportive elements, the glial cells.
However, recent results demonstrate that neurogenesis fromstem cells may occur in adult brains
Although mature skeletal muscle cells do not divide, skeletalmusc ledoes have some regenerative capacity, through the
differentiation of the satel l i te cellsthat are attached to theendomysial sheaths.
Cardiac musclehas very limited, if any, regenerative capacity,and a large injury to the heart muscle, as may occur inmyocardial infarction, is followed by scar formation.
-
8/13/2019 K7- Poliferasi
16/59
The proliferation of endometrialcells under estrogen stimulationduring the menstrual cycle and
the thyroid-stimulatinghormone-mediated replicationof cells of the thyroid thatenlarges the gland duringpregnancy are examples of
physiologic proliferationCellProlifreration
physiologic
pathologic
Pathologic condition suchas injury, cell death, andmechanical alterations oftissues also stimulate cellproliferation
-
8/13/2019 K7- Poliferasi
17/59
Physiologic stimuli may become excessive, creatingpathologic conditions such as nodular prostatic hyperplasiaresulting from dihydrotestosterone stimulation and thedevelopment of nodular goiters in the thyroid as a
consequence of increased serum levels of thyroid-stimulatinghormone.
Cell proliferationis largely controlled by signals(solubleor contact-dependent) from the microenvironment : stimulate
inhibit cell proliferation An excess of stimulators or a deficiency of inhibitors leads to
net growth and, in the case of cancer, uncontrolled growth.
Although accelerated growth can be accomplished byshortening the cell cycle, the most important mechanism of
growth is the conversion of resting or quiescent cells intoproliferating cells by making the cells enter the cell cycle.
Both the recruitment of quiescent cells into the cycle and cell-cycle progression require stimulatory signals to overcome thephysiologic inhibition of cell proliferation.
-
8/13/2019 K7- Poliferasi
18/59
M h i
-
8/13/2019 K7- Poliferasi
19/59
Mechanisms
regulating cell
populations.
Cell numberscan be altered
by increased or
decreased
rates of stemcell input, by
cell death due
to apoptosis, or
by changes inthe rates of
proliferation or
differentiation.
-
8/13/2019 K7- Poliferasi
20/59
Cell Differentiation
-
8/13/2019 K7- Poliferasi
21/59
Cellular differentiation is the
process by which an immaturecell becomes a more mature cell
Differentiation changes a cell's
size, shape, membrane potential,
metabolic activity, and
responsiveness to signals orsignal pathways
-
8/13/2019 K7- Poliferasi
22/59
The obvious changes of cell behavior that we
see as a multicellular organism develops are the
outward signs of a complex molecularcomputation, dependent on cell memory, that
is taking place inside the cells as they receive
and process signals from their neighbours and
emit signals in return. The final pattern of differentiated cell typesis
cell specializationa program played out in the
changing patterns of expression of gene
regulatory proteins, giving one cell different
potentialities from another long before terminal
differentiation begins. .
-
8/13/2019 K7- Poliferasi
23/59
The mechanism by which cells in a multicellularorganism become specialized to performspecific functions in a variety of tissues and
organs. Specialized cells are the product of
differentiation.
The process can be understood only from ahistorical perspective, and the best place tostart is the fertilized egg.
Different kinds of cell behavior can be observedduring embryogenesis: cells double, change inshape, and attach at and migrate to varioussites within the embryo without any obvious
signs of differentiation.
-
8/13/2019 K7- Poliferasi
24/59
-
8/13/2019 K7- Poliferasi
25/59
Embriogenesis
-
8/13/2019 K7- Poliferasi
26/59
-
8/13/2019 K7- Poliferasi
27/59
Th t bl diff ti t d t t i
-
8/13/2019 K7- Poliferasi
28/59
The stable differentiated state is a consequence
of multicellularity.
A complex organism maintains its characteristic
form and identity because populations of
specialized cell types remain assembled in a
certain pattern.
Thus several kinds of cells make up a tissue,
and different tissues build organs.
The variable assortment of about 200 cell types
allows for an almost infinite variety of distinctorganisms.
-
8/13/2019 K7- Poliferasi
29/59
Cell Differentiated
Stabel Stage
Cell Cell Cell Cell Cell Cell
Tissue Tissue Tissue
Organ Organ Organ
Note : The variable assortment of about 200 cell types
allows for an almost infinite variety of distinct organisms
-
8/13/2019 K7- Poliferasi
30/59
-
8/13/2019 K7- Poliferasi
31/59
Epithelia, sheets of cells of specificstructure and function, cover the outer
surface of the vertebrate body and line thelungs, gut, and vascular system.
The stable form of a vertebrate is due toits rigid skeleton built from bone andcartilage, forming cells to which theskeletal muscles adhere.
All other organs, such as liver and
pancreas, are embedded in connectivetissue that is derived from fibroblast cellswhich secrete large amounts of soft matrixmaterial
-
8/13/2019 K7- Poliferasi
32/59
-
8/13/2019 K7- Poliferasi
33/59
The renewal of terminally differentiated cellsthat are unable to divideanymore, such as skinand blood cells, is carried out by stem cells.
Stem Cell is immortal and choose, as they double,whether to remain a stem cell or to embark on apath of terminal differentiation.
Most stem cells are unipotentbecause they giverise to a single differentiated cell type.
However, all cell types of the bloodare derivedfrom a single blood-forming stem cell, a pluripotentstem cell.
A fertilized eggis atotipotentstem cell giving riseto all other cell types that make up an individualorganism
-
8/13/2019 K7- Poliferasi
34/59
C ll diff ti ti i lti ll l
-
8/13/2019 K7- Poliferasi
35/59
Cell differentiation occurs in multicellular
organisms
Normal Cells
-
8/13/2019 K7- Poliferasi
36/59
Normal Cells
Controlled growth
Contact inhibition One organized layer
Differentiated cells
Failure of ell ycle ontrolCancer Cells
Uncontrolled growth
No contact inhibition
Disorganized,multilayered
Non-differentiated cells
Abnormal nuclei
-
8/13/2019 K7- Poliferasi
37/59
Stem cells were first identified as pluripotent cells in
-
8/13/2019 K7- Poliferasi
38/59
Stem cells were first identified as pluripotent cells inembryos, and these were called embryon ic stem cel ls. It isnow clear that stem cells are also present in many tissues inadult animals and contribute to the maintenance of tissue
homeostasis. In recent years, much effort has been devoted to the isolationand phenotypic characterization of stem cells.
Among these are: the identification of stem cells and theirniches in various tissues, including the brain, which has been
considered a permanent quiescent organ the recognition that stem cells from various tissues and
particularly from the bone marrow may have broaddevelopmental plasticity
The enthusiasm about stem cell research derives both fromdata that challenge well-established biological concepts andfrom the hope that stem cells may one day be used to repairinjury in human tissues, including heart, brain, and skeletalmuscle.
-
8/13/2019 K7- Poliferasi
39/59
Embryonic Stem Cells (ES)
Embryos contain pluripotent ES cells, which can give rise toall the tissues of the human body.
Such cells can be isolated from normal blastocysts, thestructures formed at about the 32-cell stage during
embryonic development. ES cells can be maintained in culture as undifferentiated celllines or induced to differentiate into many different lineages.
The pluripotency of ES cells may be related to theexpression of unique transcription factors in these cells,
such as a recently described homeobox protein calledNanog (named after Tir na n'Og, the Celtic land of theever-young).
Recent studies also implicate the Wnt--catenin signalingin maintaining pluripotency.
-
8/13/2019 K7- Poliferasi
40/59
ES cells may, in the future, be used torepopulate damaged organs, such as the liverafter hepatocyte necrosis and the myocardium
after infarction. The generation of some specific cell types from
cultured ES cells has already been achieved.
Insulin-producing pancreatic cells and nervecells produced in these cultures have beenimplanted, respectively, in diabetic animals andin mice with neurologic defects.
Although the effectiveness of these proceduresfor human diseases is still unknown, there is anintense debate about the ethical issuesassociated with this type of therapy, which isknown as therapeutic cloning.
-
8/13/2019 K7- Poliferasi
41/59
-
8/13/2019 K7- Poliferasi
42/59
Adult Stem Cells
Many tissues in adult animals have been shownto contain reservoirs of stem cells, which arecalled adult stem cells.
Compared to ES cells, which are pluripotent,adult stem cells have a more restricteddifferentiation capacityand are usuallylineage-specific.
However, stem cell research may have come fullcircle, as stem cells with broad differentiation
potential appear to exist in adult bone marrowand, perhaps, in other tissues as well.
Stem cells located outside of the bonemarrow as generally referred to as t issue
stem cel ls.
-
8/13/2019 K7- Poliferasi
43/59
-
8/13/2019 K7- Poliferasi
44/59
Stem-cell niches in various tissues
1. Epidermal stem cells located in the bulge area
of the hair follicleserve as a stem cells for the hairfollicle and the epidermis.
2. Intestinal stem cells are located at the base of acolon crypt, above Paneth cells.
3. Liver stem cells (commonly known as ovalcells) are located in the canals of Hering ( thickarrow),structures that connect bile ductules (thinarrow)with parenchymal hepatocytes (bile duct andHering canals are stained for cytokeratin ;
4. Corneal stem cells are located in the limbusregion, between the conjunctiva and thecornea. courtesy of Tania Roskams, M.D.,University of Leuven). (Courtesy of T-T Sun, New
York University, New York, NY.)
-
8/13/2019 K7- Poliferasi
45/59
-
8/13/2019 K7- Poliferasi
46/59
Mesenchymal Stem Cell
-
8/13/2019 K7- Poliferasi
47/59
GROWTH FACTORS
There is a large number of known polypeptide
growth factors :
some of which act on many cell types
others have restricted cellular targets
In addition to stimulating cell proliferation,
growth factors may also have effects on cell
locomotion, contractility, differentiation, and
angiogenesis, activities that may be asimportant as their growth-promoting effects.
Here we review only those that have major
roles in these processes.
-
8/13/2019 K7- Poliferasi
48/59
Epidermal Growth Factor (EGF) and
-
8/13/2019 K7- Poliferasi
49/59
Epidermal Growth Factor (EGF) and
Transforming Growth Factor- (TGF-)
These two factors belong to the EGF family and share a common receptor. EGFis mitogenic for a variety of epithelial cells, hepatocytes, andfibroblasts.
It is widely distributed in tissue secretions and fluids, such as sweat,saliva, urine, and intestinal contents. In healing wounds of the skin,
EGF is produced by keratinocytes, macrophages, and other
inflammatory cellsthat migrate into the area. EGF binds to a receptor (EGFR) with intrinsic tyrosine kinase activity,
triggering the signal transduction.
TGF- was originally extracted from sarcoma virus-transformed cellsand is involved in epithelial cell proliferation in embryos and adults andmalignant transformation of normal cells to cancer.
TGF- has homology with EGF, binds to EGFR, and produces most of thebiologic activities of EGF.
The "EGF receptor" is actually a family of membrane tyrosine kinasereceptors that respond to EGF, TGF-, and other ligands of the EGF family.
The main EGFR is referred to as EGFR1, or ERB B1. The ERB B2 receptor(also known as HER-2/Neu) has received great attention because it is
overexpressed in breast cancers and is a therapeutic target
-
8/13/2019 K7- Poliferasi
50/59
Vascular Endothelial Growth Factor
-
8/13/2019 K7- Poliferasi
51/59
Vascular Endothelial Growth Factor
(VEGF)
VEGF is a family of peptides that includes VEGF-A(referred throughoutas VEGF), VEGF-B, VEGF-C, VEGF-D, and placental growth factor.
VEGF is a potent inducer of blood vessel formation in earlydevelopment (vasculogenesis)and has a central role in the growth of newblood vessels (angiogenesis)in adults.
It promotes angiogenesis in tumors, chronic inflammation, and healing
of wounds. VEGF family members signal through three tyrosine kinase receptors:
VEGFR-1, VEGFR-2, and VEGFR-3. VEGFR-2 is located in endothelialcells and is the main receptor for the vasculogenic and angiogeniceffects of VEGF.
The role of VEGFR-1 is less well understood, but it may facilitate the
mobilization of endothelial stem cells and has a role in inflammation. VEGF-C and VEGF-D bind to VEGFR-3 and act on lymphatic endothelial
cells to induce the production of lymphatic vessels (lymphangiogenesis).VEGF-B binds exclusively to VEGFR-1.
Vascular Endothelial Growth Factor (VEGF)
-
8/13/2019 K7- Poliferasi
52/59
Vascular Endothelial Growth Factor (VEGF)
Platelet-Derived Growth Factor
-
8/13/2019 K7- Poliferasi
53/59
Platelet-Derived Growth Factor
(PDGF)
PDGF is a family of several closely related proteins, each consisting of twochains designatedAand B.
All three isoforms of PDGF (AA, AB, and BB) are secreted and arebiologically active.
Recently, two new isoformsPDGF-C and PDGF-Dhave been identified.
PDGF isoforms exert their effects by binding to two cell-surface receptors,designated PDGFR and , which have different ligand specificities.
PDGF is stored in platelet granules and is released on plateletactivation.
It can also be produced by a variety of other cells, including activatedmacrophages, endothelial cells, smooth muscle cells, and many tumorcells.
PDGF causes migration and proliferation of fibroblasts, smooth musclecells, and monocytes, as demonstrated by defects in these functions inmice deficient in either the A or the B chain of PDGF.
It also participates in the activation of hepatic stellate cells in the initial stepsof liver fibrosis
Fib bl t G th F t (FGF)
-
8/13/2019 K7- Poliferasi
54/59
Fibroblast Growth Factor (FGF)
This is a family of growth factors containing more than 10 members, of which
acidic FGF (aFGF, or FGF-1) and basic FGF (bFGF, or FGF-2) are the bestcharacterized. FGF-1 and FGF-2 are made by a variety of cells. ReleasedFGFs associate with heparan sulfate in the ECM, which can serve as areservoir for storing inactive factors.
FGFs are recognized by a family of cell-surface receptors that have intrinsictyrosine kinase activity.
A large number of functions are attributed to FGFs, including the following: New b lood v essel format ion(angiogenesis):FGF-2, in particular, has the abilityto induce the steps necessary for new blood vessel formation both in vivo and invitro (see below)
Wound repair:FGFs participate in macrophage, fibroblast, and endothelial cellmigration in damaged tissues and migration of epithelium to form new epidermis.
Development:FGFs play a role in skeletal muscle development and in lung
maturation. For example, FGF-6 and its receptor induce myoblast proliferationand suppress myocyte differentiation, providing a supply of proliferatingmyocytes. FGF-2 is also thought to be involved in the generation of angioblastsduring embryogenesis. FGF-1 and FGF-2 are involved in the specification of theliver from endodermal cells.
Hematopoiesis:FGFs have been implicated in the differentiation of specificlineages of blood cells and development of bone marrow stroma.
-
8/13/2019 K7- Poliferasi
55/59
C ki
-
8/13/2019 K7- Poliferasi
56/59
Cytokines
Cytokines have important functions as
mediators of inflammation and immune
responses.
Some of these proteins can be placed intothe larger functional group of polypeptide
growth factors because they have growth-
promoting activities for a variety of cells.
-
8/13/2019 K7- Poliferasi
57/59
-
8/13/2019 K7- Poliferasi
58/59
refferences
McGraw-Hill Concise Encyclopedia of
Bioscience. 2002 by The McGraw-Hill
Companies, Inc.
2002 by Bruce Alberts, AlexanderJohnson, Julian Lewis, Martin Raff, Keith
Roberts, and Peter Walter
-
8/13/2019 K7- Poliferasi
59/59